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Abstract
5-Fluorouracil (5FU) is a chemotherapeutic drug widely used in treating a range of advanced, solid tumours and, in
particular, colorectal cancer. Here, we used high-density tiling DNA microarray technology to obtain the specific
transcriptome-wide response induced by 5FU in the eukaryotic model Schizosaccharomyces pombe. This approach
combined with real-time quantitative PCR analysis allowed us to detect splicing defects of a significant number of intron-
containing mRNA, in addition to identify some rRNA and tRNA processing defects after 5FU treatment. Interestingly, our
studies also revealed that 5FU specifically induced the expression of certain genes implicated in the processing of mRNA,
tRNA and rRNA precursors, and in the post-transcriptional modification of uracil residues in RNA. The transcription of several
tRNA genes was also significantly induced after drug exposure. These transcriptional changes might represent a cellular
response mechanism to counteract 5FU damage since deletion strains for some of these up-regulated genes were
hypersensitive to 5FU. Moreover, most of these RNA processing genes have human orthologs that participate in conserved
pathways, suggesting that they could be novel targets to improve the efficacy of 5FU-based treatments.
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Introduction
The antimetabolite 5-Fluorouracil (5FU) is an analogue of uracil
widely used as a chemotherapeutic agent in the treatment of a
variety of cancers. 5FU-based therapy has been shown to
significantly increase both the response and survival rates for
breast, neck and head cancer; however, its effectiveness is higher in
advanced colorectal tumours [1]. An understanding of its
mechanism of action is fundamental to be able to enhance the
clinical effectiveness of chemotherapy by rationally designing new
strategies as well as to enhance our knowledge of the cytotoxic
effects, which have been associated with its active metabolites. In
particular, the fluorodeoxyuridine monophosphate (FdUMP) is
known to inhibit the thymidylate synthase causing deoxynucleo-
tide pool imbalances and DNA damage [2], whereas the
fluorodeoxyuridine triphosphate (FdUTP) and the fluorouridine
triphosphate (FUTP) can be misincorporated into DNA and RNA,
respectively, interfering with normal nucleic acid metabolism [3–
5]. However, there is growing evidence that 5FU cytotoxicity may
mainly be attributable to the impairment of RNA processing
pathways. Accordingly, several experiments have shown that
uridine, but not thymidine, relieved the cytotoxic and apoptotic
effects of 5FU [1,6]. 5FU-containing RNA has been shown to
interfere with normal processing and maturation of rRNA, tRNA,
and mRNA precursors [1,4,7–9]. Although a well-established
correlation exists between the direct incorporation of 5FU into
RNA and the cytotoxic effects of the drug, the mechanism
underlying this toxicity has not been fully elucidated.
To gain further insights into the in vivo mechanism of action by
which 5FU causes RNA-based toxicity in eukaryotic cells, we used
the fission yeast Schizosaccharomyces pombe as a model organism. As
many essential cellular processes are conserved in eukaryotes, yeast
species have been proven to be powerful tools for identifying
human drug targets [10,11]. We employed high-density tiling
DNA microarray technology to perform the first whole genome
transcriptional profile associated with the 5FU response in a
eukaryotic organism. Combining this strategy with real-time
quantitative PCR (qPCR) experiments, we were able to identify
a range of processing defects of mRNA, tRNA and rRNA
precursors caused by 5FU treatment. The significant induction of
certain RNA processing genes might be associated with these drug
effects as a cellular response mechanism to counteract 5FU
damage.
Materials and Methods
Chemicals, Yeast Strains and Growth Media
5FU was obtained from Sigma-Aldrich (St. Louis, MO; Cat.
No. F6627) prepared as a 20 mM stock solution in water and kept
at 4uC. The S. pombe strains used in this study are listed in Table
S1. Haploid deletion mutants used in this study were purchased
PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e78172
from Bioneer. Cells were grown in YE (3% glucose, 0.5% yeast
extract).
Fluorescence-activated Cell Sorting Analysis
Flow cytometry was used to estimate the relative DNA content
of fission yeast cells at 0, 15, 60 or 240 minutes after 5FU
treatment. Approximately 107 cells from an exponentially growing
culture were collected by centrifugation, fixed in 70% ethanol, and
processed as previously described [12]. Analysis was performed
using FACSCalibur (Becton Dickinson) and CELLQuest software.
49, 69-Diamidino-2-phenylindole Staining and Microscopy
Ethanol-fixed cells were washed once in buffer PBS (137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 2 mM KH2PO4,
pH 7.4) and then stained with 49,69-diamidino-2-phenylindole
(DAPI, Merck) at a final concentration of 1 mg/mL. Images were
acquired on a laser-scanning confocal microscope (LSM510 Meta;
Carl Zeiss) equipped with an Axiovert 200 M.
Viability Assays
For liquid survival assays, 5FU was added to early exponentially
growing cells (OD595 = 0.2, ,46106 cells/ml). After incubation
for the indicated times, cells were plated in rich media (YE) and
colonies were counted after incubation during 3–4 days at 30uC.
For growth inhibition assays, strains were inoculated in triplicates
in a 96-well plate containing YE and grown at 30uC to saturation.
Then, they were replicated into 96-well plates with YE medium
(with or without 150 mM 5FU) using a stainless steel 96-pin
replicator (Nalgene Nunc International) and incubated at 30uC.
Growth was quantitatively scored every 24 h by monitoring the
absorbance at 595 nm with a microplate reader (Varioskan,
Thermo Scientific).
Total RNA Extraction
Cultures of S. pombe wild-type strain 972 h2 were grown in YE
medium at 30uC to OD595 = 0.2 (,46106 cells/ml). 5FU was
added to the cultures except controls to a final concentration of
500 mM and incubation was allowed to proceed for 15, 60 or 240
minutes. Total RNA was extracted using the MasterPure Yeast
RNA Purification Kit (Epicentre, Madison, WI) according to the
Figure 1. Phenotypic effects of 5FU in S. pombe cells. (A) Survival time course after 500 mM 5FU (EC50) treatment. The values represent the
means 6 s.d. of three independent experiments. (B) FACS analysis of the time course experiment indicating heterogeneity in DNA content at
240 min in 5FU-treated cells compared to untreated cells. (C) Microscopy analysis and DAPI staining show cells with elongated phenotype after 5FU
exposure for 240 min suggesting a cell cycle delay in the presence of the drug.
doi:10.1371/journal.pone.0078172.g001
Figure 2. Box and whisker plots showing the ratio of intron/
exon hybridization signal intensities after 5FU exposure. The
analysis considered 948 intron-containing transcripts of S. pombe. The
ratio represents the pre-mRNA/(mRNA+pre-mRNA) levels. The Individ-
ual boxes represent the median (central horizontal line) and the 75–
25% percentiles. The whiskers extend from the boxes to 1% and 99% of
the data set. Dots indicate outliers. Data are representative of two
independent experiments. The P values between groups were
calculated using the two-tailed Mann-Whitney test. The values at
240 min for introns SPCC24B10.17_b (5.2) and SPAC1486.01_a (4.9) are
not shown.
doi:10.1371/journal.pone.0078172.g002
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manufacturer’s recommendations. The purified RNA was imme-
diately frozen in liquid nitrogen and stored at 270uC. The quality
and quantity of total RNA were determined by Nanodrop ND-
1000 UV spectroscopy (Thermo Scientific), and RNA integrity
was checked using a 2100 Bioanalyzer (Agilent Technologies). We
obtained high-quality RNA from all the samples since the RNA
Integrity Number (RIN) was greater than 9 in each case.
Target Labelling and Microarray Hybridization
Affymetrix GeneChip S. pombe 1.0FR tiling microarray
containing 25-mer probes tiled at 20-nucleotide intervals across
both strands of the fission yeast genome were used for
measurement of DNA strand-specific expression at 0, 15, 60 or
240 minutes of 5FU exposure in two independent biological
replicates. Labelling and hybridizations were performed according
to protocols from Affymetrix. Briefly, 300 ng of total RNA were
amplified and labelled (preserving the original polarity of the
RNA) using the GeneChip whole transcript sense target labelling
assay and then hybridized to S. pombe tiling 1.0 FR Array
(Affymetrix). Washing and scanning were performed using
GeneChip System of Affymetrix (GeneChip Hybridization Oven
640, GeneChip Fluidics Station 450 and GeneChip Scanner 7G).
The Pearson correlation coefficients of the probe hybridization
signals between tiling microarray duplicates were 0.982 (t0), 0.978
(t15), 0.974 (t60) and 0.985 (t240) indicating minimum variability
between them. The complete set of microarray hybridization
results is available at the Gene Expression Omnibus (GEO)
database under accession number GSE46919.
Differential Expression Analysis of Microarray Data
To obtain a quantification of the differential gene expression
pattern we employed a previously reported protocol [13], which
processes the strand-specific hybridization signals in a quantitative
manner to create a custom Chip Description File (CDF) based on
the PomBase annotation database [14] ftp://ftp.ebi.ac.uk/pub/
databases/pombase/pombe/Chromosome_contigs/OLD/
Figure 3. Validation of selected genes rpc34, srp54 and SPAC1486.01 for intron retention after 5FU exposure. (A) Visualization of
microarray expression data. Vertical green lines represent transcription from sense DNA strand in S. pombe cells treated with 5FU for 240 min (t240) or
untreated control (t0). Red vertical lines indicate a differential over-expression level between both conditions. Genes are shown as bars pointing
towards the direction of transcription, grey sectors inside correspond to 59- and 39-untranslated regions and thin lines to introns. Boxes below
indicate the amplified exon (blue) or intron (orange) fragments showed in ‘‘B’’. (B) Absolute levels of intronic and exonic regions quantified by qPCR
for each gene transcript in untreated or 5FU-treated cells. The values represent the RNA copy number per defined ng of total RNA. Bar charts show
the average values 6 s.d. of two independent experiments. (C) Proportion of intron/exon levels (measured by the normalized ratio of intron to exon
copies). The P values between groups were calculated using the two-tailed Student’s t test. (D) Gel electrophoresis of RT-PCR products showing
prominent bands corresponding to spliced mRNA at 0 and 240 min of 5FU exposure for rpc34 (0.9 Kb), srp54 (1.6 Kb) and SPAC1486.01 (0.7 Kb) and
upper bands with the expected size of the unspliced mRNA precursors for rpc34 (1.1 Kb), srp54 (2 Kb) and SPAC1486.01 (0.8 Kb) that only appear after
drug treatment. Reverse transcriptase is omitted from the reaction for the negative control (2RT).
doi:10.1371/journal.pone.0078172.g003
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20110204). Transcriptional levels were calculated after back-
ground correction, normalization and summarization using RMA
Bioconductor package [15]. Differential expression data and the
associated P values were adjusted for multiple testing using the
Benjamini and Hochberg’s method. Limma Bioconductor package
was used to control the false discovery rate [16]. To validate the
gene expression results obtained from the microarray analysis, we
randomly picked out two RNA processing genes (ctu1 and
SPBC713.05) and two genes (ssa1 and psi1) whose human orthologs
were induced after 5FU exposure in cell cultures [17,18]. The
qPCR analysis confirmed the transcriptional changes detected
from microarrays (Figure S1). Primers for amplification reactions
are listed in Table S2.
Synthesis of cDNA for qPCR Analysis
The reverse transcription of RNA to further check the levels of
certain mRNA or rRNA regions by qPCR was performed using
the High Capacity RNA-to-cDNA Master Mix (Applied Biosys-
tems, Cat. No. 4390712) according to the manufacturer’s instruc-
tions using 500 ng of total RNA. Samples omitting reverse
transcriptase were included as negative controls in each set of
reactions. PCR primers for reverse transcription reactions (Table
S2) were designed using Primer-BLAST software (http://www.
ncbi.nlm.nih.gov/tools/primer-blast/). The specificity of each
primer pair was assessed in silico by matching them against the
complete S. pombe genome. To analyse the tRNA levels, we first
synthesized cDNA products from total RNA as follows: RNA was
denatured at 90uC for 5 min and then snap-cooled on ice for
Figure 4. Effect of 5FU in tRNA transcripts and in the viability of different tRNA modification mutants. (A) Relative levels of intronic or
exonic regions within transcripts of 9 selected tRNA genes at both 0 and 240 min of 5FU exposure quantified by qPCR. Genes for tRNAAlaCGC,
tRNAArgCCU and tRNA
Gly
CCC only have one copy in the genome, whereas multiple identical copies are found for the other tRNA genes examined. In
these cases, the amplified products detected represent a mixture of the expression levels of the individual repetitions. The values represent the
relative fold change in transcripts abundance between untreated and 5FU-treated cells normalized to the initial amount of starting RNA. Note that
only differences between the same group are directly comparable. The expression levels of the normalization gene myo1 were shown as a control.
Bar charts show the average values 6 s.d. of two independent experiments. Asterisks designate overall significance, * P,0.05, ** P,0.005, using the
two-tailed Student’s t test. T represents the amount of total tRNA (combining both spliced and unspliced transcripts), whereas I represents the intron
levels. (B) Sensitivity to 5FU of S. pombe strains deleted for genes involved in the modification of residues within tRNA molecules. The growth of the
5FU sensitive strain dus3D is also shown. Note that the control wild-type is the ED668 strain. The growth curve is representative of at least two
independent experiments.
doi:10.1371/journal.pone.0078172.g004
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10 min. Then, 600 ng of total RNA was reverse transcribed with
Super Script III First-Strand Synthesis SuperMix for qRT-PCR
(Invitrogen, Cat. No.11752) according to the manufacturer’s
recommendations except that the incubation reaction was
performed at 54uC to facilitate transcription through the highly
stable secondary structure of the tRNA. PCR primers to amplify
intronic or exonic regions within tRNA were manually designed
(Table S2). Despite the fact that many tRNA genes share sequence
similarity, primers to amplify intronic or exonic regions within the
selected tRNA genes were all specific for those regions as we only
detected a unique PCR product using melting curve analysis. Note
that genes for tRNAAlaCGC, tRNA
Arg
CCU and tRNA
Gly
CCC only
have one copy in the genome, whereas several identical copies are
found for tRNAValUAC, tRNA
Ser
GCU, tRNA
Trp
CCA, tRNA
Leu
CAA,
tRNAHisGUG and tRNA
Glu
CUC genes. Although many tRNA
molecules bearing the same anticodon do not have exactly the
same sequence, we only analysed those with identical sequences.
Real-Time Quantitative PCR Assays
Absolute quantification of cDNA derived from mRNA and
rRNA were performed in triplicates on a BioRad CFX 384
instrument with 10 mL of final reaction volume containing 5 ng of
cDNA (except for rDNA regions in which cDNA was diluted to
0.05 ng), 2.5 mM of each forward and reverse primer, and 5 mL of
Fast Sybr Green Master Mix (Applied Biosystems). The qPCR
assays were set up using an Eppendorf pipetting robot (epMotion
5075). PCR efficiency for each primer pair was calculated using 4-
fold dilutions (from 50 ng) of pooled cDNA. Cycling parameters
were as follows: 20 sec at 95uC followed by 40 two-step cycles of
95uC for 3 sec +60uC for 30 sec. Melting curve analysis from 60uC
to 95uC was included at the end of the program. Essentially, the
same protocol was used to obtain the relative quantification of
tRNA levels except for the amount of cDNA added to the
amplification reactions (1 ng) and the cycling conditions: 5 sec at
95uC followed by 40 two-step cycles of 95uC for 5 sec +62uC for
5 sec. Data analysis was performed using GenEx qPCR data
analysis software v.5.3.7 (MultiD).
Qualitative RT-PCR and Gel Electrophoresis
To visualize the presence of unspliced transcripts we performed
qualitative RT-PCR assays in a Biorad Thermal Cycler. The
amplification reactions contained 10 ng of cDNA, 1 U of Vent
DNA Polymerase (New England BioLabs), 2.5 mL of 106
ThermoPol Reaction Buffer, 1 mM of each forward and reverse
primer (Table S2), 150 mM of each dNTP and 1 mCi of [a-32P]-
CTP (3000 Ci/mmol) (Perkin-Elmer Life Science) in a final
volume of 25 mL. Cycling conditions were as follows: 92uC for
4 min, followed by 22 three-step cycles at 92uC for 45 sec +50uC
for 60 sec and 72uC for 80 sec and a final elongation step at 72uC
for 10 min. Then the PCR products were analysed by agarose gel
electrophoresis. A 1 Kb Plus DNA Ladder (Invitrogen) was used to
determine products size. Electrophoresis was carried out at room
temperature in TAE buffer (40 mM Tris, 1 mM EDTA, pH set to
7.5 with acetic acid) at 120 V for 40 min. Gels were vacuum-dried
and the radioactive bands were detected by autoradiography.
Results and Discussion
5FU Induces Cytotoxicity in S. pombe
We performed a time course analysis of S. pombe viability after
incubating cells with 500 mM 5FU (the half maximal effective
concentration dose, EC50, at 240 min) in order to evaluate the
phenotypic effects associated to drug treatment (Figure 1A). Flow
cytometry experiments revealed that 5FU-treated cells showed an
abnormal DNA content at 240 min when compared to untreated
cells (Figure 1B), probably due to a delayed entry into S phase.
Consistent with this result, 5FU has been described as a G1/S
phase blocker in human cell lines [19]. In addition, microscopy
analysis and nuclear DAPI staining showed that a proportion of
the cells treated with 5FU for 240 min became elongated with a
characteristic cell cycle delay phenotype (Figure 1C).
Global Disruption of Pre-mRNA Splicing Caused by 5FU
Despite increasing evidence that suggests that 5FU mainly
exerts its cytotoxic effects through the inhibition of RNA
metabolism, little is known about the global effects caused by
5FU in RNA processing and particularly in mRNA splicing. In
order to gain further insights into the transcriptome-wide impact
of 5FU, we took advantage of high-density tiling microarray
technology for detecting intron-containing transcripts in S. pombe.
A time-course and high-resolution survey of all differentially
transcribed regions of the genome were obtained by comparing
the transcriptional response of cells exposed to 500 mM of 5FU
during 15, 60 or 240 minutes with respect to an untreated control.
The fission yeast nuclear genome consists of 5,175 annotated
protein-coding genes, of which 2,404 are known or predicted to
contain at least one intron with an average length of 81 nucleotides
[20]. To obtain a direct measurement of intron-containing
transcripts we calculated the average probe intensity across the
948 intronic regions that were delimited by, at least, 4 core probes
in the microarray platform, since those data were deemed to be
statistically significant (Table S3). Cells treated with 5FU showed a
time-dependent global increase of unspliced transcripts, whereas
Figure 5. 5FU induces the accumulation of unprocessed rRNA
molecules. Absolute quantification of transcript levels of 5FU-treated
cells during 240 min (t240) compared to control (t0) in several regions
within the rRNA precursor. Boxes below the diagram show the specific
segments amplified by qPCR. Bar charts show the average values 6 s.d.
of two independent experiments. The P values were calculated using
the two-tailed Student’s t test.
doi:10.1371/journal.pone.0078172.g005
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the exon levels (representing a measure of both mature mRNA
and pre-mRNA levels) did not significantly change, ruling out the
possibility that these alterations were an indirect consequence of
increments in the transcription rates (Figure S2). Consistent with
this result is the fact that the levels of intronic regions relative to
their corresponding flanking exons (intron/exon ratio) were
significantly higher at 60 and 240 min after drug exposure than
the untreated control (P,0.05 and P,0.0001, respectively)
(Figure 2). In particular, more than 1.5-fold increase was detected
for 12% of the genes at 60 min and 27.7% at 240 min of 5FU
treatment (Table S3).
To validate these results, we selected three genes (rpc34, srp54
and SPAC1486.01) whose transcripts exhibited an increase in
intron retention after 240 min of 5FU treatment, according to
tiling microarray analysis (Table S3 and Figure 3A). Reverse
transcription followed by qPCR experiments that amplified
specific intron or exon segments, revealed that the percentage of
intron-containing transcripts detected were between,2 and 8-fold
higher than the untreated control (Figure 3B, 3C). The analysis of
qualitative reverse transcriptase-PCR products on agarose gel
electrophoresis further confirmed the presence of these unspliced
transcripts (Figure 3D).
Taken together, our findings provide a novel global insight into
pre-mRNA splicing defects that previously were only reported for
a limited number of transcripts when exposed to 5FU [9,21,22].
The direct misincorporation of the 5FU metabolite FUTP into the
mRNA precursors could possibly contribute to these alterations by
preventing efficient splice site recognition and/or cleavage.
However, several studies have shown that the splicing machinery
efficiently processed 5FU-substituted pre-mRNA [9,23]. This
apparent contradiction could be explained if the incorporation
of 5FU into the RNA components of the splicing machinery were
the main cause of the processing defects reported rather than the
5FU-substitutions into substrate RNA. This hypothesis is support-
ed by the fact that the incorporation of 5FU into the small nuclear
RNAs (snRNA), which are key components of the spliceosome,
caused impairment of pre-mRNA splicing [9,24].
Effects of 5FU on Expression and Splicing of tRNA
Intron-containing transcripts from protein-coding genes are not
the only type of RNA molecules that undergo splicing in
eukaryotic cells. A number of tRNA genes also contain introns
that must be removed by an enzymatic cut-and-rejoin reaction
Table 1. 5FU induced RNA processing genes in S. pombe.
Gene Name Annotationa
Human
orthologb
t15 vs
t0 FC P
t60 vs
t0 FC P
t240 vs
t0 FC P
mRNA processing
SPAP8A3.06 Splicing factor U2AF 23 kDa subunit U2AF1 2.5 0.01 1.8 0.03
hub1 Ubiquitin-like modifier hub1 HUB1 1.7 0.01 1.8 0.01
ini1 Pre-mRNA-splicing factor ini1 PHF5A 1.5 0.02 1.6 0.03
prp38 Pre-mRNA-splicing factor 38 PRPF38A 1.7 0.03
snu66 U4/U6.U5 tri-snRNP-associated protein snu66 SART1 2.0 0.01
prp11 Pre-mRNA-processing ATP-dependent RNA helicase DDX46 1.7 ,0.01
SPBC713.05 Uncharacterized WD repeat-containing protein C713.05 WDR83 1.7 0.03
sap49 Spliceosome-associated protein 49 SF3B4 1.5 ,0.01
aar2 A1 cistron-splicing factor aar2 AAR2 1.5 0.05 1.5 0.03
tRNA processing
tum1 Putative 3-mercaptopyruvate sulfurtransferase TST, MPST 1.9 0.02
SPAC10F6.04 RCC1 repeat-containing protein C10F6.04 SERGEF 1.8 ,0.01
sen54 Probable tRNA-splicing endonuclease subunit sen54 TSEN54 1.6 ,0.01
SPAC12B10.08c Probable tRNA(Ile)-lysidine synthase 1.6 ,0.01
mss1 tRNA modification GTPase mss1, mitochondrial GTPBP3 1.6 0.02
ctu1 Cytoplasmic tRNA 2-thiolation protein 1 CTU1 1.5 0.01 1.9 ,0.01
ctu2 Cytoplasmic tRNA 2-thiolation protein 2 CTU2 1.6 0.02
rRNA processing
esf2 Pre-rRNA-processing protein esf2 ABT1 1.6 ,0.01 2.0 ,0.01 1.7 ,0.01
cgr1 rRNA-processing protein cgr1 1.6 0.01 1.6 ,0.01 1.8 ,0.01
SPAC227.02c Ribosomal RNA-processing protein 15 RRP15 1.6 0.04 1.5 0.02
mrm2 rRNA (uridine-2’-O-)-methyltransferase FTSJ2 1.5 0.04
SPCC757.08 Exosome complex component rrp45 EXOSC9 1.6 ,0.01
Footnotes:
aAnnotation provides a schematically description of the gene product as indicated in UniprotKB database (http://www.uniprot.org/). Genes were classified according to
their function in Gene Ontology (GO) groups using PomBase Database (http://www.pombase.org/spombe/query/builder).
bPotential human orthologue genes or functional counterparts found in Homologene (http://www.ncbi.nlm.nih.gov/homologene/) and KOGs classification (http://www.
ncbi.nlm.nih.gov/COG/grace/kognitor.html).
Abbreviation: FC, Fold change in gene expression after 15 min, 60 min or 240 min of 5FU treatment. Only values higher than the threshold (1.5) were shown. P values
(P) were calculated as described in Materials and Methods.
doi:10.1371/journal.pone.0078172.t001
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that requires the heterotetrameric tRNA splicing endonuclease
(SEN) complex to generate the mature and functional structure.
Using the tRNAscan-SE program (Genomic tRNA Database,
http://gtrnadb.ucsc.edu) a total of 186 tRNA genes were
identified in S. pombe, 44 of which have introns (24% of the total)
ranging in size from 7 to 30 nucleotides [25]. To test whether the
pre-tRNA splicing was affected by 5FU, we compared the levels of
unspliced transcripts after 240 min of drug exposure respect to the
untreated control for four selected intron-containing tRNA genes
that code for tRNAAlaCGC, tRNA
Arg
CCU, tRNA
Leu
CAA and
tRNASerGCU (Figure 4A). Specific intronic or exonic regions
within each tRNA were amplified using reverse transcription and
qPCR experiments. A comparison of the intron to exon ratios at 0
and 240 min of 5FU treatment for each type of tRNA transcript
revealed that only tRNAArgCCU showed a statistically significant
increase in intron retention (1.2-fold higher, P = 0.05). The results
also indicated that cell exposure to 5FU for 240 min had an
enhanced expression of the selected intron-containing tRNA genes
(Figure 4A). This finding led us to ask whether the levels of non
intron-containing tRNA were also affected. The analysis showed
that the amount of transcripts detected for tRNAHisGUG,
tRNATrpCCA, tRNA
Gly
CCC, tRNA
Val
UAC and tRNA
Glu
CUC were
notably higher after 5FU exposure, although their levels were
lower than those in most of the intron-containing tRNA genes
examined (Figure 4A).
To our knowledge, this is the first time that an increase in the
tRNA levels has been observed in cells treated with 5FU. Previous
studies reported that the 5FU-containing tRNA is able to form
stable complexes with the tRNA pseudouridine synthase [26] and
the tRNA 5-methyluridine-methyltransferase [27] causing the
inhibition of both enzymatic activities. The subsequent sequestra-
tion of tRNA molecules and the presumable decrease in levels of
pseudouridine and 5-methyluridine modifications, which stabilize
specific structural tRNA motifs, may induce the expression of the
tRNA genes. Accordingly, strains lacking these genes might have
an increased sensitivity to 5FU. To test this, we analysed the effects
Figure 6. Sensitivity to 5FU of different mutants affected in RNA processing pathways. Strains deleted for genes involved in the
processing of mRNA (A), tRNA (B) or rRNA (C) were tested for 5FU sensitivity. Mutants grew at near wild-type rates on liquid medium but exhibited
reduced growth rates when 5FU was added to the cultures with the exception of the strain mss1D. The growth of the 5FU sensitive strain dus3D and
the control wild-type (ED668) is also shown. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0078172.g006
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of 5FU in S. pombe strains deleted for pus1, which encodes the only
enzyme with demonstrated tRNA pseudouridine synthase activity
[28], and trm2, a gene predicted to encode the only tRNA
(m5U54) methyltransferase (Figure 4B). A strain deleted for dus3,
the ortholog of the Saccharomyces cerevisiae tRNA dihydrouridine
synthase 3 whose deletion increased the sensitivity to 5FU [29],
was used as a control. The unexpected resistance of the trm2D cells
(Figure 4B) could be explained if the protein plays a role in DNA
repair, like its ortholog TRM2 in S. cerevisiae does, as this activity
has the potential to promote cell cycle arrest in response to 5FU
treatment, as previously shown for other enzymes involved in
DNA repair pathways [30]. In contrast, the pus1D strain was
highly sensitive to 5FU compared to the wild-type one (Figure 4B).
These findings support previous research, which suggested that
pseudouridine modifications are relevant targets for 5FU [29].
Based on these results, it would be expected that the inhibition of
the pseudouridine metabolizing enzymes could also contribute to
the cytotoxicity of 5FU. To test this hypothesis we examined the
drug sensitivity of a strain disrupted for SPBC1861.05, a gene
predicted to encode the only fission yeast enzyme able to modify
(by phosphorylation) pseudouridine residues. The viability assays
showed that this modification could be also one of the targets of
5FU, as the strain SPBC1861.05D was hypersensitive to the drug
(Figure 4B).
Defective Pre-rRNA Processing Caused by 5FU
Several studies have shown the capacity of 5FU to inhibit the
processing of pre-rRNA into mature rRNA [7,31,32], the most
abundant type of RNA in eukaryotic cells. In S. pombe the major
rRNAs are transcribed from the 100–120 tandem repeats of the
rDNA locus into a single precursor that contains the sequences for
the mature 18S, 5.8S, and 28S rRNA separated by two internal
transcribed spacers, ITS1 and ITS2 (Figure 5) [33]. The nuclear
exosome, a highly conserved RNA processing complex, plays a
critical role in the series of cleavage events required to generate
mature rRNA molecules [34]. A genome-wide screen to assess the
cellular effects of several chemical compounds in S. cerevisiae
revealed that 5FU produces the accumulation of an rRNA
processing product that includes a part of the ITS1 and ITS2
segments [32]. To further investigate whether 5FU causes a similar
impairment in fission yeast, we compared the amount of
transcripts detected by qPCR from several regions of the rRNA
transcript after 240 min of drug treatment to the amount found in
untreated cells (Figure 5). The expression levels for the 18S, ITS1,
5.8S, and 28S regions did not show any statistically significant
differences; however, a significant 1.65-fold increase (P,0.05) was
observed for ITS2 suggesting a defective pre-rRNA processing
associated with the 5FU treatment in S. pombe.
5FU Induces the Transcription of Genes Involved in RNA
Processing Pathways
Next we explored whether the observed RNA processing defects
produced by 5FU in S. pombe caused a transcriptional activation
response of the genes involved in such a pathway. To test this
prediction, the expression levels of the genes involved in the
processing of mRNA (180), tRNA (103) and rRNA (202) were
evaluated at 0, 15, 60 or 240 min after drug exposure and the
significantly up-regulated ones (greater than 1.5-fold, P,0.05)
were identified (Table 1). RNA processing genes that were known
to respond to multiple types of environmental stresses [35] were
not included in order to only evaluate the specific response to 5FU.
One of the most interesting up-regulated genes is snu66, which,
like gene prp38, encodes a subunit of the U4/U6.U5 pre-mRNA
splicing small nuclear ribonucleoprotein (snRNP) complex. The
human homologue of yeast Snu66, called SART1, is essential for
the recruitment of the tri-snRNP to the pre-spliceosome [36].
Microarray expression profilings of metastatic colorectal cancer
patient biopsies have recently revealed that SART1 transcription
was up-regulated following 5FU treatment [37]. In addition,
silencing of SART1 with siRNA (small interfering RNA)
synergistically enhanced the apoptotic effects of 5FU in several
colorectal cancer cell lines.
Another intriguing finding was the up-regulation of hub1, a gene
encoding a Snu66 binding protein [38], which has been implicated
in enabling the spliceosome to tolerate and to use some non-
canonical 59 splice sites. Relaxing the specificity of the spliceosome
would be one of the cellular mechanisms to bypass the deleterious
effect produced by the direct incorporation of 5FU into mRNA
transcripts, or even into the small nuclear RNAs (snRNA) that are
necessary for an efficient intron removal process. We also found
that aar2, a gene required for the correct assembly of this
spliceosomal tri-snRNP, was induced.
Moreover, SPAP8A3.06 [39], ini1 [40] and sap49 [41] gene
products are components of the U2 snRNP complex that binds to
the intronic region at the branch site to generate a prespliceosome
that is partially stabilized by Prp11 [42]. SPBC713.05 encodes a
protein purified as part of the spliceosome [43].
5FU also affects the expression of genes potentially involved in
several post-transcriptional modifications of the tRNA wobble
uridine, such as thiolation (tum1, ctu1 and ctu2) and the formation
of 5-methoxycarbonylmethyl (SPAC10F6.04) [44,45] and 5-
carboxymethylaminomethyl (mss1) groups [46]. It has been
suggested that the absence of these modifications may influence
decoding. SPAC12B10.08c is predicted to ligate lysine onto the
cytidine present at the wobble position 34 of the tRNAIleAUA, thus
changing the amino acid specificity from methionine to isoleucine
in the mitochondria [47]. On the other hand, the induction of
sen54 expression, a gene with a potential role in tRNA precursors
maturation, suggests that 5FU could alter the splicing of some
tRNA introns, as in the case of tRNAArgCCU transcripts
(Figure 4A). Furthermore, it might be possible that some human
tRNA genes show splicing defects after 5FU treatment, since the
mechanism of tRNA splicing has been conserved through
evolution [48].
The induction of various rRNA metabolic genes, such as cgr1,
predicted to be required in the processing of the pre-rRNA for the
60S ribosome subunit [49], esf2, implicated in pre-18S rRNA
processing [50] and SPCC757.08 (rrp45), involved in the generation
of mature 5.8S rRNA transcripts could be related to the defects
found in rRNA maturation steps (Figure 5). In fact, Rrp45 is a
component of the nuclear exosome complex that has been
previously shown to be one of the main cellular targets for 5FU
in S. cerevisiae [32]. Mrm2, a gene encoding a methyltransferase
required for 29-O-ribose methylation of the uracil at position 2,791
of yeast mitochondrial 21S rRNA [51] was also induced,
suggesting the possibility that the catalytic activity of this enzyme
might be impaired if 5FU arises at that position instead of uracil.
It is interesting to note that many of the up-regulated RNA
processing genes are implicated in uridine modifications that
substantially decrease after 5FU treatment, indicating the high
specificity of the cellular response to the drug.
Sensitivity to 5FU of Mutants Defective in RNA
Processing Genes
In previous studies, the analysis of the transcriptional changes
associated with 5FU exposure mainly focused on the comparison
between 5FU sensitive and resistant tumour cell lines in order to
identify biomarkers for predicting the efficacy of chemotherapeutic
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response [52–54]. However, gene expression profiles of cancer
cells that were exposed to drug agents have been shown to
correlate with drug sensitivity in several studies [55,56]. Accord-
ingly, the up-regulation of the RNA processing genes shown in
Table 1 might reflect a cellular attempt to counteract the
damaging effects of 5FU, and thus the deletion of some of these
genes could enhance 5FU-induced apoptosis. To check this
possibility, we selected S. pombe haploid mutants deleted for
individual genes involved in RNA processing (Table 1) that are not
essential for yeast viability.
The growth curve analysis revealed that strains aar2D, cgr1D,
ctu1D, mrm2D and SPBC713.05D were more sensitive to 5FU than
the wild-type control (Figure 6). However, the strain mss1D did not
exhibit hypersensitivity to 5FU (Figure 6B), suggesting a modest
contribution of this gene to the 5FU response or functional
redundancy with other RNA processing genes. In this regard, the
absence of SPBC30B4.06c, a protein required for Mss1 to modify
uridine bases in mitochondrial tRNA, caused a reduction in the
growth rates when 5FU was added to the cultures (Figure 6B). In a
recent analysis, heterozygous deletion S. pombe strains were tested
for sensitivity to several drugs, including 5FU [57]. Interestingly,
sen54D and tum1D mutants showed an increased sensitivity to 5FU
as predicted from our results.
Regardless of the specific mechanism, it seems clear that RNA
processing pathways contribute to some extent to 5FU toxicity
since mutants in a number of RNA processing proteins exhibit
increased sensitivity to the drug. This result suggests that a
combined treatment of 5FU with a new generation of antitumor
drugs that have the spliceosome as its main target (spliceostatin,
pladienolide) [58] could improve the efficacy of the drug. The
splicing defects could directly activate apoptosis as might occur in
the case of some traditional anticancer agents like cisplatin, which
is capable of affecting the splicing of apoptotic genes [59].
Plenty of evidence suggests that RNA-based effects play a
prominent role in 5FU cytotoxicity; however, the significance of
the thymidylate synthase inhibition has also been largely proved.
Multiple clinical studies have shown that a low tumoral
thymidylate synthase expression is a predictive marker for a high
response to 5FU-based chemotherapy [60,61]. Alternatively, the
down-regulation of the enzyme transcription in cancer cell lines
considerably enhanced 5FU efficacy [62]. We checked that the
deletion of the human thymidylate synthase ortholog in S. pombe
(SPAC15E1.04) also improved the drug sensitivity (Figure S3),
which provides additional evidence for validating the new
candidates we propose as 5FU targets.
In conclusion, the analysis of the global transcriptional changes
associated with 5FU exposure revealed a range of processing
defects in RNA precursors as well as an increase in tRNA levels
and an induction of several RNA processing genes. The deletion of
many of these genes conferred sensitivity to 5FU showing that the
transcriptional response can be used to predict potential drug
targets. Further studies will be needed to determine whether
lowering the levels of the corresponding human orthologs could
increase the cellular sensitivity to 5FU treatment.
Supporting Information
Figure S1 Validation of microarray data using qPCR
analysis. We randomly selected two RNA processing genes (ctu1
and SPBC713.05) and two genes (ssa1 and psi1) whose orthologs in
humans were induced after 5FU treatment. The expression levels
obtained by qPCR (A) or microarray experiments (B) were
compared after 15, 60 and 240 min of drug exposure with respect
to untreated cells. For normalization, the expression level of the
commonly used qPCR normalisation gene myo1 was set to 1. Bars
represent average data for two independent biological replicates
with each of the individual data points displayed by a cross.
(PDF)
Figure S2 Box and whisker plots showing the average of the
probe intensities (Log2 scale) obtained by microarray experiments
for the intronic (A) or exonic (B) regions of 948 intron-containing
transcripts after exposure S. pombe cells for 0, 15, 60 and 240 min
to 5FU. Individual boxes represent the median (central horizontal
line) and the 75–25% percentiles. The whiskers extend from the
boxes to minimum and maximum values. The data shown are
representative of two independent experiments. The indicated P
values between groups were calculated using the two-tailed Mann-
Whitney test. No statistically significant differences were found in
the signal intensity of exonic regions among different times.
(PDF)
Figure S3 Sensitivity to 5FU of the S. pombe strain
deleted for the thymidylate synthase gene. The yeast strain
deleted for SPAC15E1.04 (the predicted ortholog of the human
thymidylate synthase gene) was hypersensitive to 5FU. The growth
of the 5FU sensitive strain dus3D and the control wild-type
(ED668) is also shown. Data are representative of three
independent experiments.
(PDF)
Table S1 Genotype of S. pombe strains used in this study.
(PDF)
Table S2 List of primers used in this study.
(PDF)
Table S3 Expression levels of intronic and exonic regions for
948 intron-containing transcripts detected by microarray analysis.
A probe-filtering protocol was employed to process the hybrid-
ization signals in a quantitative manner to measure differential
transcriptional expression as described in Materials and Methods.
Genes were listed according to their systematic name. The
subscript denotes the position within the gene of the intron that we
examined (for example SPAC10F6.10_b correspond to the second
intron of that particular ORF). Only introns delimited by a
minimum of 4 core probes (nprobes) were analysed. Results for
experiment 1 (t0_1, t15_1, t60_1 and t240_1) and 2 (t0_2, t15_2,
t60_2 and t240_2) are indicated. P values were calculated using
the two-tailed Student’s t test.
(PDF)
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